{"log_id": 1311861366934705519, "direction": 0, "words_result_num": 26, "words_result": [{"probability": {"variance": 0.00025, "average": 0.993922, "min": 0.909582}, "location": {"width": 835, "top": 230, "height": 41, "left": 177}, "words": "升高1.5倍。阿昔替尼与强效CYP3A4/5抑制剂(例如酮康唑、伊曲康唑、克拉霉素"}, {"probability": {"variance": 3.9e-05, "average": 0.995921, "min": 0.97312}, "location": {"width": 838, "top": 285, "height": 41, "left": 176}, "words": "红霉素、阿扎那韦、茚地那韦、奈法唑酮、那非那韦、利托那韦、沙奎那韦及泰利霉素)"}, {"probability": {"variance": 3.5e-05, "average": 0.997232, "min": 0.971788}, "location": {"width": 846, "top": 341, "height": 40, "left": 177}, "words": "合用可能升高阿昔替尼血浆浓度。葡萄柚也可能升高阿昔替尼血浆浓度。建议选择无或"}, {"probability": {"variance": 0.005061, "average": 0.97811, "min": 0.658799}, "location": {"width": 837, "top": 396, "height": 40, "left": 176}, "words": "有最低程度CYP3A4/5抑制可能性的药物合用。如果必须与强效CYP3A4/5抑制剂合用"}, {"probability": {"variance": 8.7e-05, "average": 0.994454, "min": 0.968589}, "location": {"width": 429, "top": 456, "height": 35, "left": 177}, "words": "建议调整阿昔替尼的剂量(见【用法用量】)"}, {"probability": {"variance": 0.00928, "average": 0.94396, "min": 0.651102}, "location": {"width": 165, "top": 514, "height": 28, "left": 184}, "words": "CYP3A4/5诱导剂"}, {"probability": {"variance": 0.000537, "average": 0.992357, "min": 0.853099}, "location": {"width": 800, "top": 560, "height": 38, "left": 222}, "words": "利福平是CYP3A4/5的强效诱导剂,在健康志愿者中以600mg每日一次的剂量给"}, {"probability": {"variance": 0.004665, "average": 0.979987, "min": 0.673959}, "location": {"width": 730, "top": 613, "height": 40, "left": 177}, "words": "药9天,使单剂量5mg阿昔替尼的平均AUC降低79%,使Cmax降低71%"}, {"probability": {"variance": 0.006031, "average": 0.979775, "min": 0.529766}, "location": {"width": 792, "top": 666, "height": 41, "left": 221}, "words": "阿昔替尼与强效CYP3A4/5诱导剂(例如利福平、地塞米松、苯妥英、卡马西平"}, {"probability": {"variance": 0.000287, "average": 0.994415, "min": 0.894956}, "location": {"width": 843, "top": 722, "height": 40, "left": 179}, "words": "利福布汀、利福喷汀、苯巴比妥及贯叶连翘[也称作圣约翰草])合用可能降低阿昔替尼"}, {"probability": {"variance": 0.005997, "average": 0.978682, "min": 0.53301}, "location": {"width": 848, "top": 775, "height": 43, "left": 179}, "words": "血浆浓度。建议选择无或有最低程度CYP3A4/S诱导可能性的药物合用。如果必须与强"}, {"probability": {"variance": 0.002171, "average": 0.985816, "min": 0.750241}, "location": {"width": 699, "top": 832, "height": 39, "left": 178}, "words": "效CYP3A4/5诱导剂合用,建议调整阿昔替尼的剂量(见【用法用量】"}, {"probability": {"variance": 0.035154, "average": 0.640039, "min": 0.376557}, "location": {"width": 143, "top": 810, "height": 66, "left": 867}, "words": "修不"}, {"probability": {"variance": 0.005337, "average": 0.952392, "min": 0.763371}, "location": {"width": 280, "top": 894, "height": 29, "left": 179}, "words": " CRPIA2和CYP2C19抑制剂"}, {"probability": {"variance": 0.000375, "average": 0.992184, "min": 0.896646}, "location": {"width": 803, "top": 940, "height": 39, "left": 224}, "words": "少量阿昔替尼(<10%)经 CYPIA2和CYP2C19代谢。尚未研究这些同工酶的强"}, {"probability": {"variance": 4.3e-05, "average": 0.997939, "min": 0.959228}, "location": {"width": 847, "top": 995, "height": 39, "left": 179}, "words": "效抑制剂对阿昔替尼药代动力学的影响。由于这些同工酶的强效抑制剂可能会增加阿昔"}, {"probability": {"variance": 2e-06, "average": 0.999008, "min": 0.994982}, "location": {"width": 272, "top": 1057, "height": 30, "left": 181}, "words": "替尼血浆浓度,因此应慎用"}, {"probability": {"variance": 3.7e-05, "average": 0.995455, "min": 0.975404}, "location": {"width": 357, "top": 1110, "height": 34, "left": 180}, "words": "CYP和UGT抑制和诱导的体外研究"}, {"probability": {"variance": 0.001075, "average": 0.989177, "min": 0.789551}, "location": {"width": 794, "top": 1157, "height": 40, "left": 225}, "words": "体外研究表明治疗血浆浓度下,阿昔替尼不抑制CYP2A6、CYP2C9、CYP2C19"}, {"probability": {"variance": 0.000808, "average": 0.983327, "min": 0.86344}, "location": {"width": 425, "top": 1219, "height": 32, "left": 185}, "words": "CYP2D6、CYP2E1、CYP3A4/5或 UGTIAI"}, {"probability": {"variance": 0.00321, "average": 0.981728, "min": 0.691106}, "location": {"width": 803, "top": 1266, "height": 40, "left": 225}, "words": "体外研究表明阿昔替尼可能抑制 CYPIA2。因此,阿昔替尼与 CYPIA2底物合用可"}, {"probability": {"variance": 0.021267, "average": 0.952431, "min": 0.453183}, "location": {"width": 479, "top": 1328, "height": 34, "left": 182}, "words": "能导致CYPI1A2底物(例如茶碱)血浆浓度升高"}, {"probability": {"variance": 0.000838, "average": 0.988312, "min": 0.842182}, "location": {"width": 800, "top": 1377, "height": 42, "left": 228}, "words": "体外研究还表明阿昔替尼可能抑制CYP2C8。然而,阿昔替尼与紫杉醇(一种已知"}, {"probability": {"variance": 0.000113, "average": 0.994481, "min": 0.952648}, "location": {"width": 847, "top": 1432, "height": 43, "left": 183}, "words": "的CYP2C8底物)合用,没有导致晚期癌症患者的紫杉醇血浆浓度升高,表明缺乏临床"}, {"probability": {"variance": 6.9e-05, "average": 0.991318, "min": 0.978546}, "location": {"width": 138, "top": 1584, "height": 24, "left": 541}, "words": "第15页,共27页"}, {"probability": {"variance": 0.002041, "average": 0.972927, "min": 0.857065}, "location": {"width": 95, "top": 1614, "height": 19, "left": 243}, "words": "No;20150429"}], "language": 3}